132 related articles for article (PubMed ID: 1499470)
21. [Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications].
Thivolet C; Ayzac L; Simonet C; Rebattu B; Bernard P; Tourniaire J
Presse Med; 1990 Jun; 19(23):1075-80. PubMed ID: 2141408
[TBL] [Abstract][Full Text] [Related]
22. Plasma prorenin as an early marker of microvascular disease in patients with diabetes mellitus.
Franken AA; Derkx FH; Blankestijn PJ; Janssen JA; Mannesse CK; Hop W; Boomsma F; Weber R; Peperkamp E; De Jong PT
Diabete Metab; 1992; 18(2 Pt 2):137-43. PubMed ID: 1322326
[TBL] [Abstract][Full Text] [Related]
23. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
24. Atherogenic lipids and vascular complications in a selected diabetic population with normal urinary albumin/creatinine ratios.
Kodali VR
Diabetes Metab Syndr; 2014; 8(2):124-7. PubMed ID: 24907179
[TBL] [Abstract][Full Text] [Related]
25. Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects.
Chaiken RL; Khawaja R; Bard M; Eckert-Norton M; Banerji MA; Lebovitz HE
Diabetes Care; 1997 May; 20(5):709-13. PubMed ID: 9135931
[TBL] [Abstract][Full Text] [Related]
26. The relationship between mean platelet volume with microalbuminuria and glycemic control in patients with type II diabetes mellitus.
Ünübol M; Ayhan M; Güney E
Platelets; 2012; 23(6):475-80. PubMed ID: 22122310
[TBL] [Abstract][Full Text] [Related]
27. Microalbuminuria, as predictor of late diabetic complications. A prospective study.
Fekete T; Bogdan E; Crăciunescu C
Med Interne; 1990; 28(2):131-4. PubMed ID: 2270422
[TBL] [Abstract][Full Text] [Related]
28. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.
Groop L; Ekstrand A; Forsblom C; Widén E; Groop PH; Teppo AM; Eriksson J
Diabetologia; 1993 Jul; 36(7):642-7. PubMed ID: 8359582
[TBL] [Abstract][Full Text] [Related]
29. Symptoms and complications of adult diabetic patients in a family practice.
Konen JC; Curtis LG; Summerson JH
Arch Fam Med; 1996 Mar; 5(3):135-45. PubMed ID: 8620254
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance.
Fujimoto WY; Leonetti DL; Kinyoun JL; Shuman WP; Stolov WC; Wahl PW
Diabetes; 1987 Jun; 36(6):730-9. PubMed ID: 3569672
[TBL] [Abstract][Full Text] [Related]
31. Hyperinsulinemia in type II diabetic patients with microalbuminuria.
Trevisan R; Orrasch M; Jori E; Tiengo A
Diabetes Care; 1993 Aug; 16(8):1211. PubMed ID: 8375255
[No Abstract] [Full Text] [Related]
32. Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria.
Fruehwald-Schultes B; Kern W; Beyer J; Forst T; Pfützner A; Peters A
Metabolism; 1999 Oct; 48(10):1290-3. PubMed ID: 10535393
[TBL] [Abstract][Full Text] [Related]
33. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
[TBL] [Abstract][Full Text] [Related]
34. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes.
Powrie JK; Watts GF; Ingham JN; Taub NA; Talmud PJ; Shaw KM
BMJ; 1994 Dec; 309(6969):1608-12. PubMed ID: 7819935
[TBL] [Abstract][Full Text] [Related]
35. Impact of microangiopathy on chronic symptomatic peripheral neuropathy.
Jennings PE; Nightingale S; Lawson N; Hoffman P; Williamson JR; Barnett AH
Diabetes Res; 1990 Feb; 13(2):51-4. PubMed ID: 2091870
[TBL] [Abstract][Full Text] [Related]
36. The association between diabetic complications and exercise capacity in NIDDM patients.
Estacio RO; Regensteiner JG; Wolfel EE; Jeffers B; Dickenson M; Schrier RW
Diabetes Care; 1998 Feb; 21(2):291-5. PubMed ID: 9539998
[TBL] [Abstract][Full Text] [Related]
37. Urinary albumin excretion rate and cardiovascular disease in Spaniard type 2 diabetic patients.
Relimpio F; Pumar A; Losada F; Molina J; Maynar A; Acosta D; Astorga R
Diabetes Res Clin Pract; 1997 May; 36(2):127-34. PubMed ID: 9229197
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with diabetic microangiopathy: a study of 157 type I (insulin-dependent) diabetic patients.
Billault BM; Passa PL
J Diabet Complications; 1991; 5(4):238-43. PubMed ID: 1779019
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and correlations of early microvascular complications in young type I diabetic patients: role of puberty.
Bognetti E; Calori G; Meschi F; Macellaro P; Bonfanti R; Chiumello G
J Pediatr Endocrinol Metab; 1997; 10(6):587-92. PubMed ID: 9467128
[TBL] [Abstract][Full Text] [Related]
40. The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes.
Isomaa B; Henricsson M; Almgren P; Tuomi T; Taskinen MR; Groop L
Diabetologia; 2001 Sep; 44(9):1148-54. PubMed ID: 11596670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
